Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 275 results for "zydus group cadila healthcare"

Cadila Healthcare to acquire Claris Lifesciences for Rs 3,400 ...

Mumbai: Cadila Healthcare, the Zydus Cadilla Group flagship, has emerged as the frontrunner to acquire the generic sterile injectables business of Ahmedabad-headquartered Claris Lifesciences Ltd (CLL) trumping several domestic and global peers who ... India Brand Equity Foundation, 2 hours ago

2 images for "zydus group cadila healthcare"

India Infoline, 1 week ago
Times of India, 17 hours ago
Odisha Samaya

Zydus Cadila Q4 net up 46%; revenues jump 16%

Related to : Zydus Wellness Ltd,Cadila Healthcare Ltd Zydus Wellness Ltd BSE 15 May 15 | 03:34 PM 970.00 -30.9 (-3.09%) NSE 15 May 15 | 03:40 PM 971.20 -29.15 (-2.91%) Ahmedabad-based drug major Cadila Healthcare Ltd, has posted ...
 Smart Investor6 days ago Cadila Healthcare consolidated net surges by 46% in Q4, dividend at 240%  PharmaBiz1 week ago Zydus Cadila Q4 net profit up 46%  Livemint.com6 days ago Cadila Healthcare launches Hepatitis C drug SoviHep  Odisha Samaya2 months ago
[x]  
Livemint.com

Zydus Cadila launches Gilead's Hepatitis C drug in India

The company said that the medicine will be marketed by the speciality division of the group, Zydus Heptiza. New Delhi: Drug firm Zydus Cadila on Tuesday launched a generic version of Gilead Sciences hepatitis C drug Sofosbuvir in India under the ...
 Livemint.com2 months ago Zydus Cadila Launches Generic Version of Gilead Sciences Hepatitis C drug in India  Topnews.in2 months ago
[x]  

Zydus Group to Donate USD 240,000 to The National Institutes of Health, USA for Advancing Leishmaniasis Research

/PRNewswire/ -- Etna Biotech, the Vaccine R & D subsidiary of Zydus, announced a collaborative program with the National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health, for advancing leishmaniasis ...
 Wall Street Business Network4 weeks ago
[x]  

Coal India, BS and Cadila Healthcare to see some action today

SENSEX 27802.00 35.21 0.13% NIFTY 8408.10 15.15 0.18% Industries: Airlines/Aviation, Metal and Mining, ...
 Finalaya.com1 day ago
Moneycontrol.com

Cadila to Seek Investors' Nod to Raise up to Rs 10,000 Cr

New Delhi : Cadila Healthcare Ltd plans to seek "an enabling approval" from its shareholders to raise up to Rs 10,000 crore via issue of different securities. The company's board, which met on Wednesday, decided to seek shareholders' nod to issue ...
 NDTV Profit1 month ago Cadila to seek shareholders' nod to raise up to Rs 10,000 crore  Jagran Post1 month ago

Cadila Healthcare gains on announcing a collaborative program with the National Institute of Alle...

Cadila Healthcare is currently trading at Rs. 1755.80, up by 7.35 points or 0.42 % from its previous closing of Rs. 1748.45 on the BSE. The scrip opened at Rs. 1770.00 and has touched a high and low of Rs. 1770.00 and Rs. 1742.20 respectively. So ...
 Arihant Capital4 weeks ago Cadila Healthcare gains on inking non-exclusive licensing pact with Gilead Sciences  Arihant Capital2 months ago Zydus Cadila, Gilead Sciences ink non-exclusive licensing pact  Indian-Commodity2 months ago
Moneycontrol.com

Zydus ties up with US-based R&D to develop vaccine

Pharmaceuticals major Zydus today said that its R&D subsidiary Etna Biotech will collaborate with US-based National Institute of Allergy and Infectious Diseases (NIAD) to develop a vaccine against visceral leishmaniasis (VL), known as Kala-Azar in ...
 Hindu Business Line4 weeks ago Zydus ties up with US-based research centre to develop vaccine  Daily Excelsior.com4 weeks ago Zydus ties up with US-based RD centre to develop vaccine  Moneycontrol.com4 weeks ago
[x]  
India Infoline

Cadila spurts 4% at opening bell

News Top News Top Story India Infoline News Service | Mumbai | March 18, 2015 09:36 IST New drug launch by Zydus group boosts sentiment at the counter. Cadila Healthcare spurted ...
 India Infoline2 months ago

Pieris Pharmaceuticals to Present Data on Novel Anti-CD137 and HER2 Bispecific Immuno-Oncology Program at UBS Global Healthcare Conference

) - Pieris Pharmaceuticals, Inc . ( OTCQB: PIRS ), a biotechnology company advancing its proprietary Anticalin ® biotherapeutic technologies, announced today that President and CEO, Stephen Yoder, will present preclinical data on a new ...
 RCL Advisors2 days ago PIERIS PHARMACEUTICALS : to Present Data on Novel Anti-CD137 and HER2 Bispecific Immuno-Oncology Program at UBS Global Healthcare Conference  4 Traders2 days ago Pieris Pharmaceuticals, Inc. (PIRS: OTCQB) | Pieris Pharmaceuticals to Present at the 2015 UBS Global Healthcare Conference on May 19th, 2015  OTC Markets2 weeks ago Pieris Pharmaceuticals to Present at the 2015 UBS Global Healthcare Conference on May 19th, 2015  MoneyShow.com2 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - zydus group cadila healthcare
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less